New Hybrid Capture method for comprehensive genome analysis
Since mid-2015, a new Hybrid-Capture based genetic analysis method is available within the framework of the network NGM. In one approach this method tests a very comprehensive panel of 83 oncogenes and can determine multiple genetic aberrations (mutations, deletions, amplifications, translocations) in one process. In this very comprehensive approach to the analysis of cancer genomes, numerous genes are detected that are of great importance for therapeutic decisions in other malignant tumors, including, for example, colorectal, gastric and esophageal cancer (see Gastrointestinal Cancer Group Cologne).
The Network Genomic Medicine will therefore ensure that within the framework of this diagnostics, new molecular biomarkers, which are of crucial importance for all therapies, known or still in clinical testing, are determined continuously.
Further information about the new Hybrid-Capture method will follow soon.